19 Recruiting Clinical Stage III Gastric Cancer AJCC v8 Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Related Conditions
Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 (3)Clinical Stage IV Gastric Cancer AJCC v8 (3)Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 (3)Metastatic Gastroesophageal Junction Adenocarcinoma (3)Metastatic Gastric Adenocarcinoma (2)Unresectable Gastroesophageal Junction Adenocarcinoma (2)
Top Recruiting Clinical Stage III Gastric Cancer AJCC v8 Studies
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors
📍 UT MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔